ISSN

Scope:

The Journal of Rare Diseases and Orphan Drugs (JRDOD) is a peer-reviewed open-access medical journal that publishes original research, reviews, case reports, and letters covering a broad field of its specialty. We intend to publish articles that are stimulating to read, educate, and inform readers with the most up-to-date research in genetics, rare diseases, and new orphan drug development in different stages of clinical trials. Journal topics center on patients living with undiagnosed rare diseases, the importance of a diagnosis, individual approaches to treatments.

We are looking for papers from rare disease medical experts to contribute and share their knowledge.  
Aims:

  • To fill a niche for practical information about physiological, pharmacological, psychological, and pathological forces that lead to the development of rare diseases.
  • To afford an international platform for meaningful interdisciplinary collaboration to promote safe, effective, and affordable global patient care with rare disease conditions.
  • To connect conventional and evidence-based complementary medicine to produce overall wellness.
  • To address all aspects of the patients’ life related to the rare disease conditions, including, but not limited to psychological aspects, caregiver support, medical care availability, multidisciplinary team approach.

View the journal's  Editorial Board

Announcements

Happy New Year

2020-12-16

Dear Readers! Happy Holliday season!

The Journal of Rare Diseases and Orphan Drugs (JRDOD) a double-blind peer-reviewed journal with a strong adherence to publishing ethics. 

Papers can be sent after the registration to https://spphllc.com/JRDOD

The JRDOD is not yet indexed in PubMed/Medline, Web of Science, and Scopus. The Publisher is taking all the necessary steps for immediate and automatic article deposit to all these indexing services as soon as the journal meets the thresholds for consideration of new publications, with the hope that we will be indexed as soon as possible. Once indexed, all published Rare Diseases and Orphan Drugs manuscripts will be indexed.

We are looking forward to seeing and publishing your work.

Tetyana Vasylyeva, MD, PhD

Editor-in-Chief

refertan@fastmail.fm

Read more about Happy New Year

Current Issue

Vol. 2 (2021)
Published: 2020-12-31

Articles

View All Issues